Code | 2212D | ||||||||||
MA number | 44/0238/19-S | ||||||||||
Product Form: | tbl 30x10 mg (blis.Al/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Vipharm S.A., Poland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 01.08.2019 |
Validity: | 01.08.2024 |
MA renewed: | Renewal application submitted |
SPC: | SPC_Everolimus Vipharm 10 mg tablety_03.2023.pdf |
PIL: | PIL_Everolimus Vipharm 10 mg tablety_03.2023.pdf |
Safety feature | Yes |
Data update: | 27.03.2023 |